The leading global health technology platform digitising operating rooms (“OR”), announces a partnership with U.S.-based medical technology company, Imperative Care – with the aim of driving the development of a robotic surgical system to treat ischemic stroke. Imperative Care researches, develops and…
Varian, a Siemens Healthineers company, today announced the European launch of IntelliBlate, its next generation microwave ablation solution, for the treatment of soft tissue tumors. Now CE-marked, IntelliBlate represents a pivotal milestone in expanding access to an integrated, intuitive, and…
Aviva Biopharm Reveals Promising Preclinical Results for d3-T, a First-in-Class Women’s Testosterone Therapy, at ENDO 2025 Aviva Biopharm Inc. (Aviva Bio), a clinical-stage biopharmaceutical company developing next-generation hormone therapies for women, announced today that new preclinical data on its lead…
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced an update to their voluntary licensing agreement with the Medicines Patent Pool (MPP) for cabotegravir to include patents relating to its…
Simulations Plus, a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced an investment of $1 million in technology company Nurocor. Founded in 2017, Nurocor offers a cloud-based software platform designed to…
SBC Medical Group Appoints Renowned Plastic Surgery Expert Dr. Steven R. Cohen as Medical Strategy Advisor to Drive Global Expansion SBC Medical Group Holdings (headquarters: California, USA; CEO: Yoshiyuki Aikawa) is pleased to announce that Dr. Steven R. Cohen, a…
AdventHealth and Anthem Blue Cross Blue Shield of Georgia Ink Multi-Year Deal to Broaden Access to Quality Care in Northwest Georgia AdventHealth and Anthem Blue Cross Blue Shield of Georgia (Anthem) are pleased to announce a new multi-year contractual agreement…
HistoSonics , maker of the Edison® Tissue Ablation System , today announced that Highmark Blue Cross Blue Shield has issued four new positive medical policy decisions for the use of Tissue Ablation technology in the treatment of liver tumors. The decisions expand…
Elegen , a leading next-generation DNA manufacturer, and Nutcracker Therapeutics , a global leader in next-generation RNA design and manufacturing, today announced the launch of a pilot program to demonstrate the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer therapeutics…
CEL-SCI to Partner With Leading Saudi Pharma Firm to Advance Multikine for Head and Neck Cancer Treatment Today announced it has reached an agreement with one of Saudi Arabia’s premier pharmaceutical and healthcare companies for a partnership that spans regulatory…
A global leader in next-generation DNA manufacturing, and Nutcracker Therapeutics, a global leader in next-generation RNA design and manufacturing, today announced the launch of a pilot program to demonstrate the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer…
Parse Biosciences, a leading provider of easy-to-use and scalable single-cell sequencing solutions, today announced that a groundbreaking study published in Science used Parse’s single-cell technology to reveal how signaling pathways drive the formation of multiple neuronal subtypes. By linking specific signals to cell fate…